Search Results 241-250 of 10479 for Cholangitis
About this study. To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Primary sclerosing cholangitis (PSC) causes inflammation and scarring of the bile ducts. This rare liver disease is often accompanied by inflammatory bowel ...
Study To Evaluate The Safety, Tolerability, PDs, And Efficacy Of CNP-104 In Subjects With Primary Biliary Cholangitis · Share · Facebook · Twitter.
... cholangitis (PBC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...
Global Prospective, Observational Cohort of Adult Patients with Primary Sclerosing Cholangitis (WIND-PSC Study) ... Clinically diagnosed acute cholangitis and ...
Primary sclerosing cholangitis is a chronic inflammation of the bile ducts of unknown cause and eventually results in cirrhosis of the liver. These patients are ...
A Study To Evaluate Efficacy And Safety Of An Investigational Drug Named Volixibat In Patients With Itching Caused By Primary Biliary Cholangitis.
The purpose of this study is to evaluate the safety and effectiveness of curcumin used in patients with primary sclerosing cholangitis. Participation ...
Mayo Clinic researcher Nidhi Jalan Sakrikar, Ph.D., studies the mechanisms underlying fibroinflammatory signaling in primary sclerosing cholangitis.
The purpose of this study is to assess the safety, tolerability and effectiveness of LJN452 for the treatment of patients who have primary biliary cholangitis.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.